Trial Profile
Population analysis of ramosetron for postoperative nausea and vomiting
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Ramosetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- Acronyms ramosetron PONV
- 29 May 2014 New trial record